dilated cardiomyopathy: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
432914 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2159 |
4. Check minimum number of eventsNone |
2159 |
5. Include endpointsNone |
2159 |
6. Filter based on genotype QC (FinnGen only) |
2159 |
Control definitions (FinnGen only)
- Control conditions
- not I9_IHD
and not I9_HYPERTROCARDMYOP
Extra metadata
- First used in FinnGen datafreeze
- DF3
Nonischemic cardiomyopathy
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 16110 | 4481 | 11483 |
| Only index persons | 13468 | 3839 | 9629 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.27 | 0.13 | 0.32 |
| Only index persons | 0.30 | 0.14 | 0.37 |
| Median age at first event (years) | |||
| Whole population | 59.56 | 62.32 | 58.44 |
| Only index persons | 59.28 | 61.85 | 58.25 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2159 | 619 | 1540 |
| Unadjusted period prevalence (%) | 0.54 | 0.21 | 0.68 |
| Median age at first event (years) | 59.03 | 58.65 | 59.18 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1962
- Matched controls
- 19621
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
22.3
323.0
606
385
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
31.2
323.0
1050
698
C07AB07
ATC
bisoprolol; oral
13.3
323.0
1624
5193
201
Kela drug reimbursment
Chronic cardiac insufficiency
175.3
323.0
1050
128
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
25.7
323.0
489
250
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
223.6
323.0
513
31
C03CA01
ATC
furosemide; systemic
15.6
323.0
1368
2526
I50.0
ICD-10 Finland
Congestive heart failure
23.8
323.0
508
284
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
8.8
323.0
978
1998
C03DA01
ATC
spironolactone; oral
29.0
323.0
1055
757
C09AA05
ATC
ramipril; oral
10.2
323.0
1157
2419
I50.1
ICD-10 Finland
Left ventricular failure
75.6
323.0
626
121
AN1
HP
Coronary angiography
30.3
323.0
508
223
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
12.9
323.0
977
1397
I50.9
ICD-10 Finland
Heart failure, unspecified
31.7
323.0
1096
752
I42.0
ICD-10 Finland
Dilated cardiomyopathy
4503599627370496.0
323.0
1915
*
B01AA03
ATC
warfarin; systemic
6.9
276.1
845
1929
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
2808.7
272.2
257
*
C01AA05
ATC
digoxin; systemic
13.7
270.2
499
477
207
Kela drug reimbursment
Chronic arrhythmias
7.6
247.3
670
1252
C09DX04
ATC
valsartan and sacubitril; oral
2477.4
243.8
231
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
5.8
237.2
862
2352
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
21.2
236.1
360
206
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
2046.6
205.8
196
*
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
57.0
195.9
232
46
C01BD01
ATC
amiodarone; systemic
27.5
193.3
270
113
XF404
NOMESCO Finland
Ambulatory ECG
7.0
164.1
449
795
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
159.6
1180
5715
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
34.0
155.6
205
67
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
7.0
148.1
404
704
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
751.2
143.9
140
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
4.8
136.2
528
1393
I47.2
ICD-10 Finland
Ventricular tachycardia
26.8
129.2
181
74
TFP20
NOMESCO Finland
Cardiodefibrillation
6.2
119.2
353
672
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
4.8
118.9
454
1160
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
96.9
115.6
127
14
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
113.6
477
1334
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
24.8
109.0
156
68
GD1LA
NOMESCO Finland
GD
24.5
107.2
154
68
XF400
NOMESCO Finland
ECG with 12 standard connections
3.9
105.9
508
1595
FPE37
NOMESCO Finland
Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
1073.7
105.3
102
*
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
134.4
96.0
102
8
I50
ICD-10 Finland
Heart failure
15.6
94.6
159
110
K77
ICPC
Heart failure
25.1
94.2
134
57
FPE96
NOMESCO Finland
Other implantation or replacement of transvenous cardiac pacemaker
117.0
92.9
100
9
81
HP
Angiography of the heart and coronary arteries
19.8
92.5
142
77
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
312.7
88.5
89
*
1CX08
NOMESCO Finland
NA
186.3
85.9
89
5
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
17.0
83.2
135
85
R06.0
ICD-10 Finland
Dyspnoea
3.0
83.0
585
2404
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
6.1
82.9
243
446
I42.8
ICD-10 Finland
Other cardiomyopathies
67.3
78.2
90
14
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
24.5
76.2
109
47
WX892
NOMESCO Finland
Monitored bed care
4.9
73.2
260
593
K78
ICPC
Atrial fibrillation/flutter
4.7
72.9
270
644
K84
ICPC
Heart disease other
14.3
68.7
119
88
B01AF02
ATC
apixaban; oral
3.8
62.1
291
859
I42
ICD-10 Finland
Cardiomyopathy
317.2
60.7
61
*
AP1
HP
Catheterization of the left side of the heart
36.6
57.6
74
21
Z2221
NOMESCO Finland
Medical doctor
2.4
56.9
619
3154
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
25.6
56.3
79
32
C07AG02
ATC
carvedilol; oral
4.6
54.5
204
486
ZXE00
NOMESCO Finland
One hour or less
2.2
54.5
819
4846
ZXD05
NOMESCO Finland
Urgent procedure
2.3
54.1
623
3252
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
34.5
53.9
70
21
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
11.6
53.8
102
92
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
6.3
53.6
150
256
I51.1
ICD-10 Finland
Rupture of chordae tendineae, not elsewhere classified
+∞
52.3
50
*
TFJ02
NOMESCO Finland
Muscle biopsy of heart
184.9
52.2
54
*
M04AA01
ATC
allopurinol; systemic
2.9
52.1
362
1416
ZX120
NOMESCO Finland
Intravenous
3.4
51.7
275
892
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
35.9
51.3
66
19
FPJ24
NOMESCO Finland
Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
261.9
50.3
51
*
A10BK01
ATC
dapagliflozin; oral
5.0
50.1
169
360
250
Kela drug reimbursment
NA
256.4
49.3
50
*
XF640
NOMESCO Finland
NA
6.9
47.6
123
188
TFP34
NOMESCO Finland
Electrophysiological investigation
6.7
47.4
126
200
XF402
NOMESCO Finland
ECG with work load test
3.4
47.3
249
798
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
47.2
467
2231
AP4
HP
Myocardial biopsy
128.2
47.0
50
*
Z94.1
ICD-10 Finland
Heart transplant status
74.9
45.2
51
7
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
44.9
267
934
ASB
HP
Insertion of a biventricular physiological pacemaker DDD (R)
230.1
44.1
45
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
42.6
378
1691
I49.3
ICD-10 Finland
Ventricular premature depolarization
3.8
42.2
190
535
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
7.1
41.9
106
157
Z3231
NOMESCO Finland
Registered nurse
2.1
41.6
593
3331
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
13.0
41.4
74
59
R4110
NOMESCO Finland
Physiotherapy
2.1
41.2
569
3152
WX872
NOMESCO Finland
Intensive care
4.8
41.0
142
311
I48.2
ICD-10 Finland
Chronic atrial fibrillation
6.8
40.7
106
164
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
8.1
39.5
91
117
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
13.5
38.8
68
52
C07AA07
ATC
sotalol; systemic
5.1
38.1
126
262
4254A
ICD-9 Finland
Cardiomyopathy, Other primary cardiomyopathies
136.0
37.8
40
*
C07AB02
ATC
metoprolol; systemic
2.4
37.8
359
1657
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
37.5
754
4804
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
37.3
193
607
I44.2
ICD-10 Finland
Atrioventricular block, complete
6.9
37.3
96
146
R02
ICPC
Shortness of breath/dyspnoea
2.8
36.6
257
998
TFP47
NOMESCO Finland
Ablation or modification of the AV-node
41.8
36.3
45
11
B01AB05
ATC
enoxaparin; parenteral
2.0
36.0
618
3697
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.9
36.0
158
434
XF409
NOMESCO Finland
Other special ECG
22.2
35.8
52
24
M10.9
ICD-10 Finland
Gout, unspecified
3.3
35.7
197
650
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
35.4
498
2750
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
+∞
34.5
33
*
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
342.8
34.0
34
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
32.8
467
2578
AS8
HP
Physiological arrhythmia pacemaker insertionDDD (R) S
+∞
32.4
31
*
XFE00
NOMESCO Finland
Epicardial ultrasonography
7.0
30.9
78
116
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
162.5
30.8
32
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.2
29.9
169
566
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
3.7
29.9
135
380
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
5.5
29.8
90
169
FPE40
NOMESCO Finland
Replacement of transvenous cardiac pacemaker electrode
24.6
29.2
41
17
127
Kela drug reimbursment
Transplant complication
6.6
29.0
76
119
C09AA02
ATC
enalapril; systemic
2.1
29.0
406
2213
H02AB06
ATC
prednisolone; systemic
1.7
28.9
877
6241
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
28.3
289
1368
A12BA01
ATC
potassium chloride; oral
4.4
28.2
106
252
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
3.3
28.0
149
478
FPE36
NOMESCO Finland
Implantation of biventricular cardioverter-defibrillator with ventricular electrodes
285.3
27.8
28
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.1
27.1
154
517
FPE25
NOMESCO Finland
Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)
62.9
27.0
31
5
I48.1
ICD-10 Finland
Persistent atrial fibrillation
5.2
27.0
85
168
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
274.6
26.8
27
*
AS6
HP
Biventricular physiological heart failure pacemaker insertion DDD (R)
274.6
26.8
27
*
WX740
NOMESCO Finland
Nitrogen oxide therapy
141.9
26.7
28
*
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
4.2
26.3
104
260
FL1AC
NOMESCO Finland
Left cardioangiography
18.5
26.1
40
22
L04AA06
ATC
mycophenolic acid; systemic
6.1
25.8
71
119
E66.01
ICD-10 Finland
Obesity due to excess calories
3.0
25.7
157
554
A46
ICD-10 Finland
Erysipelas
2.2
25.6
300
1510
FM1JR
NOMESCO Finland
Heart, extensive metabolic PET with CT
44.9
25.5
31
7
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
25.1
192
778
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
9.8
24.8
50
52
A10BK03
ATC
empagliflozin; oral
2.8
24.6
168
635
TK800
NOMESCO Finland
Hemodialysis
5.2
24.5
77
152
C09AA04
ATC
perindopril; oral
3.3
24.4
127
400
I49.5
ICD-10 Finland
Sick sinus syndrome
4.5
24.0
87
200
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
87.8
23.7
26
*
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
3.8
22.2
97
266
B01AF01
ATC
rivaroxaban; oral
2.2
21.9
249
1229
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
21.3
662
4628
Z3226
NOMESCO Finland
Physiotherapist
1.9
21.2
347
1983
FPG40
NOMESCO Finland
Replacement of pulse generator in transvenous cardioverter-defibrillator
60.7
20.9
24
*
4259X
ICD-9 Finland
Cardiomyopathy, Secondary cardiomyopathy, unspecified
+∞
20.9
20
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
20.8
282
1500
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.3
20.5
207
968
A10BA02
ATC
metformin; oral
1.7
20.4
511
3347
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
7.4
20.2
48
66
I42.6
ICD-10 Finland
Alcoholic cardiomyopathy
32.9
20.2
26
8
FPJ23
NOMESCO Finland
Revision of biventricular cardioverter-defibrillator with ventricular electrodes
+∞
19.8
19
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
19.8
495
3241
T90
ICPC
Diabetes non-insulin dependent
1.8
19.7
436
2750
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.7
19.3
66
144
I41.8*D86.8
ICD-10 Finland
Sarcoid myocarditis
46.5
19.2
23
5
E87.5
ICD-10 Finland
Hyperkalaemia
6.3
19.1
51
83
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
15.0
18.9
31
21
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.4
18.9
95
293
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
5.6
18.8
55
101
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.9
18.7
121
442
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
13.0
18.4
32
25
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
18.4
211
1042
K99
ICPC
Cardiovascular disease other
4.1
18.4
73
185
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
18.2
1337
15173
N18.8
ICD-10 Finland
Other chronic renal failure
4.1
18.2
71
177
C01DA14
ATC
isosorbide mononitrate; oral
3.7
18.2
80
222
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
18.0
257
1388
3AC01
NOMESCO Finland
NA
7.7
17.9
41
54
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
17.8
294
1675
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.0
17.6
70
178
TFP35
NOMESCO Finland
Electroanatomical mapping
5.5
17.4
51
94
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
5.0
17.4
56
115
A11CC03
ATC
alfacalcidol; systemic
4.5
17.4
62
142
AA1AD
NOMESCO Finland
CT of head and brain
1.7
17.2
426
2765
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
17.1
502
3410
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
17.1
60
135
ATX
HP
Other pacemaker replacement or related action, such as cord removal or replacement
50.4
17.0
20
*
I47.1
ICD-10 Finland
Supraventricular tachycardia
3.2
16.9
92
301
FPG42
NOMESCO Finland
Replacement of electrode(s) in transvenous cardioverter-defibrillator
+∞
16.7
16
*
FXE00
NOMESCO Finland
Use of ECLA
90.8
16.6
18
*
7AX01
NOMESCO Finland
NA
90.8
16.6
18
*
Z2446
NOMESCO Finland
Social worker
2.5
16.6
135
567
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.8
16.6
107
393
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
6.0
16.5
45
76
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
16.5
131
543
FM1DM
NOMESCO Finland
Heart very extensive MRI examination with 3 Tesla magnet
40.4
16.3
20
5
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
16.2
126
515
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
16.2
450
3010
FN1AD
NOMESCO Finland
CT of coronary arteries
7.7
16.1
37
49
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
5.1
16.1
51
103
WX722
NOMESCO Finland
PEEP
2.7
16.1
112
430
A10BH05
ATC
linagliptin; oral
2.9
16.1
99
352
62
HP
Catheterization and pressure measurement of the right side of the heart
30.3
16.1
21
7
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
6.8
16.0
40
60
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
13.7
16.0
27
20
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
16.0
160
744
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
9.0
15.9
33
37
C09CA03
ATC
valsartan; oral
2.1
15.9
179
879
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
60.5
15.8
18
*
FPE24
NOMESCO Finland
Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)
60.5
15.8
18
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
15.7
194
987
FPJ22
NOMESCO Finland
Revision of cardioverter-defibrillator with atrial and ventricular electrodes
+∞
15.6
15
*
R03BB04
ATC
tiotropium bromide; inhalant
2.1
15.5
193
986
AQ1
HP
Conventional electrophysiological examination
7.1
15.4
37
53
E66.8
ICD-10 Finland
Other obesity
2.8
15.1
97
355
R2110
NOMESCO Finland
Giving the first information
2.7
15.0
105
405
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.0
15.0
193
999
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.7
14.8
104
402
I34.1
ICD-10 Finland
Mitral (valve) prolapse
3.5
14.8
68
197
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
14.5
140
641
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
14.4
289
1755
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.7
14.3
100
385
FPJ00
NOMESCO Finland
Revision of pacemaker pulse generator or electrode
22.4
14.2
20
9
T92
ICPC
Gout
4.0
13.9
55
140
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.9
13.9
38
65
E05.89
ICD-10 Finland
Other thyrotoxicosis
17.7
13.8
21
12
B01AE07
ATC
dabigatran etexilate; oral
2.8
13.7
86
311
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.8
13.7
58
157
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
13.7
75
248
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
9.1
13.7
28
31
M10
ICD-10 Finland
Gout
2.5
13.7
107
440
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
13.7
163
821
C10AA05
ATC
atorvastatin; oral
1.5
13.6
590
4364
WX930
NOMESCO Finland
Thepapeutic hypothermia
75.6
13.6
15
*
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.8
13.5
89
332
M01AH05
ATC
etoricoxib; oral
0.7
13.3
707
8792
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.8
13.2
87
324
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
5.5
13.2
38
70
FPJ
NOMESCO Finland
Review and replacement of pacemaker or internal defibrillator device or electrode
15.1
13.1
21
14
AP2
HP
Catheterization of the right side of the heart
16.8
13.0
20
12
A10BH01
ATC
sitagliptin; oral
2.0
13.0
172
902
61
HP
Catheterization and pressure measurement of the left side of the heart
13.1
12.9
22
17
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
19.2
12.9
19
10
N02BE01
ATC
paracetamol; systemic, rectal
1.5
12.9
1534
13811
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
12.9
342
2245
E66.00
ICD-10 Finland
Metabolic syndrome
2.4
12.8
108
462
TK810
NOMESCO Finland
Hemofiltration
8.1
12.8
28
35
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
12.3
12.6
22
18
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
+∞
12.5
12
*
C01EB17
ATC
ivabradine; oral
+∞
12.5
12
*
63
HP
Cardiac muscle biopsy
+∞
12.5
12
*
AP3
HP
Catheterization of the right and left side of the heart
17.4
12.5
19
11
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
12.5
673
5187
R55
ICD-10 Finland
Syncope and collapse
1.9
12.4
182
992
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
12.4
122
565
FPW96
NOMESCO Finland
Other operation for arhythmia or disturbance of impulse propagation
11.7
12.3
22
19
R00.1
ICD-10 Finland
Bradycardia, unspecified
3.3
12.3
61
189
I44.1
ICD-10 Finland
Atrioventricular block, second degree
4.0
12.3
48
122
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.0
12.2
38
77
Z71.8
ICD-10 Finland
Other specified counselling
1.6
12.1
362
2443
I44.6
ICD-10 Finland
Other and unspecified fascicular block
26.9
12.0
16
6
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.5
12.0
90
363
R03AC02
ATC
salbutamol; inhalant
1.4
11.9
836
6760
ARB
HP
Catheter ablation of arrhythmia: Cutiing or modification of the AV node
46.9
11.9
14
*
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
5.9
11.8
32
55
AS4
HP
Physiological pacemaker insertion DDD (R)
5.7
11.8
33
59
FA1AC
NOMESCO Finland
Upper cavography
65.3
11.6
13
*
H02AB07
ATC
prednisone; oral
1.7
11.6
236
1433
TFP32
NOMESCO Finland
Cathetric treatmen of cardiac arrythmia
8.7
11.5
24
28
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.5
11.5
87
352
ASA
HP
Insertion of a biventricular pacemaker VVI (R) S
+∞
11.5
11
*
283
Kela drug reimbursment
Ivabradine
+∞
11.5
11
*
B01AB04
ATC
dalteparin; parenteral
2.4
11.5
97
418
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
13.7
11.4
19
14
R1420
NOMESCO Finland
Assessment of rehabilitation needs and/or compilation of rehabilitation plan
120.7
11.4
12
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
120.7
11.4
12
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
11.4
104
465
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.1
11.4
60
195
WX002
NOMESCO Finland
Sedation and analgesia
1.6
11.3
342
2315
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
11.3
103
459
73
HP
Initial pacemaker installation
10.6
11.3
21
20
I45.9
ICD-10 Finland
Conduction disorder, unspecified
6.2
11.2
29
47
J01MA14
ATC
moxifloxacin; systemic
1.9
11.2
156
832
R4190
NOMESCO Finland
Nutritional therapy
2.6
11.2
79
309
C09CA01
ATC
losartan; oral
1.5
11.1
402
2837
C01BC04
ATC
flecainide; systemic
2.7
11.1
75
286
3A064
NOMESCO Finland
NA
11.2
11.0
20
18
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.9
11.0
35
73
C08DA01
ATC
verapamil; systemic
2.7
10.9
72
268
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.9
10.8
34
70
XA800
NOMESCO Finland
Neuropsychological investigation
2.4
10.8
87
366
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.0
10.8
62
213
M10.0
ICD-10 Finland
Idiopathic gout
2.6
10.7
78
308
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.3
10.7
38
89
71
HP
Electrophysiological Special Examination
7.6
10.7
24
32
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
10.6
167
932
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
10.6
116
562
R04.0
ICD-10 Finland
Epistaxis
2.1
10.6
125
626
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.8
10.6
43
114
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
10.6
111
530
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.6
10.5
75
295
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
10.5
131
673
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
+∞
10.4
10
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.0
10.4
138
725
FPJ21
NOMESCO Finland
Revision of cardioverter-defibrillator with ventricular electrode
32.7
10.3
13
*
H03BB01
ATC
carbimazole; oral
2.8
10.3
64
231
ZX108
NOMESCO Finland
Inhalation
5.8
10.3
28
49
74
HP
Initial installation of the atrial pacemaker
18.9
10.3
15
8
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
10.2
347
2408
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.9
10.2
158
879
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
10.1
453
3338
G47.3
ICD-10 Finland
Sleep apnoea
1.5
10.1
394
2821
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
6.5
10.0
25
39
WX902
NOMESCO Finland
External defibrillation of heart
9.2
10.0
20
22
WX882
NOMESCO Finland
High dependency care
2.9
10.0
60
214
I41.8
ICD-10 Finland
Myocarditis in other diseases classified elsewhere
40.3
10.0
12
*
S97
ICPC
Chronic ulcer skin
2.2
9.9
99
462
C10AA01
ATC
simvastatin; oral
1.4
9.8
676
5399
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
4.6
9.7
32
70
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
9.7
77
323
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
3.7
9.5
40
110
J01MA12
ATC
levofloxacin; systemic
1.5
9.4
321
2227
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
9.4
178
1058
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.2
9.4
48
154
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
4.1
9.3
35
87
A41.8
ICD-10 Finland
Other specified sepsis
3.7
9.3
39
107
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
9.2
140
775
J01DB01
ATC
cefalexin; oral
1.4
9.1
1453
13209
E86
ICD-10 Finland
Volume depletion
3.1
9.1
47
152
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
9.1
66
264
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
15.6
9.0
14
9
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
8.9
88
411
J01CA04
ATC
amoxicillin; systemic
1.4
8.8
1357
12225
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.9
8.8
137
763
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.2
8.8
89
420
R4120
NOMESCO Finland
Occupational therapy
2.0
8.8
105
532
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
8.7
302
2104
A10BJ06
ATC
semaglutide; parenteral
2.7
8.7
59
226
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
8.7
438
3291
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.3
8.7
81
368
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
8.7
117
620
I95.9
ICD-10 Finland
Hypotension, unspecified
4.5
8.7
29
65
Z2445
NOMESCO Finland
Psychologist
2.4
8.6
70
298
C03AA03
ATC
hydrochlorothiazide; oral
1.8
8.6
145
831
S18
ICPC
Laceration/cut
1.3
8.6
713
5833
A12AA04
ATC
calcium carbonate; oral
3.8
8.5
34
90
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.0
8.4
32
81
C01BA01
ATC
quinidine; oral
7.4
8.4
19
26
I51.3
ICD-10 Finland
Intracardiac thrombosis, not elsewhere classified
90.4
8.4
9
*
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
2.5
8.4
62
251
Z94.0
ICD-10 Finland
Kidney transplant status
4.2
8.4
30
72
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.2
8.3
86
409
FWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of heart and major thoracic vessels
+∞
8.3
8
*
FPJ12
NOMESCO Finland
Revision of biventricular CRT-P (DDDR) generator
+∞
8.3
8
*
TFP52
NOMESCO Finland
Ablation treatment of ventricular tachycardia due to structural heart defect
+∞
8.3
8
*
FXM00
NOMESCO Finland
Removal of extra-, para- or intracorporeal VAD
+∞
8.3
8
*
SPAT1263
SPAT
Sampling
1.3
8.3
660
5359
R50.9
ICD-10 Finland
Fever, unspecified
1.6
8.3
221
1445
WX110
NOMESCO Finland
Local anesthesy
1.3
8.1
1166
10321
F1279
NOMESCO Finland
NA
33.5
8.1
10
*
C09AA01
ATC
captopril; oral
3.5
8.1
35
100
742
NOMESCO Finland
NA
10.1
8.0
15
15
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.9
8.0
21
36
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.0
8.0
93
468
N19
ICD-10 Finland
Unspecified kidney failure
2.5
7.9
58
234
M01AC06
ATC
meloxicam; systemic, rectal
0.7
7.9
355
4638
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.9
7.8
30
77
5AB14
NOMESCO Finland
NA
10.8
7.8
14
13
C02EA02
ATC
NA
2.2
7.8
72
327
C07AB03
ATC
atenolol; systemic
2.1
7.7
86
422
XF406
NOMESCO Finland
High resolution ECG
45.1
7.7
9
*
WX900
NOMESCO Finland
Resuscitation
15.1
7.7
12
8
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
7.7
159
971
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
7.7
597
4814
SPAT1325
SPAT
Vaccination
1.4
7.7
528
4178
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
7.6
74
345
Z50.0
ICD-10 Finland
Cardiac rehabilitation
11.9
7.6
13
11
XFP02
NOMESCO Finland
NA
25.1
7.6
10
*
FM1EE
SPAT
NA
6.2
7.5
19
31
A10BJ02
ATC
liraglutide; parenteral
2.8
7.5
45
162
G04BE03
ATC
sildenafil; oral
2.9
7.5
43
149
72
HP
Catheter ablation of arrhythmia
7.1
7.5
17
24
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
3.7
7.4
30
81
A28
ICPC
Limited function/disability NOS
1.6
7.4
221
1483
FM1BG
NOMESCO Finland
MRI examination of heart with high intensity magnet
80.4
7.4
8
*
160
Kela drug reimbursment
exenatide
2.9
7.4
41
141
WX890
NOMESCO Finland
Intesive care monitoring
6.5
7.4
18
28
K83
ICPC
Heart valve disease NOS
4.6
7.4
24
53
FPE26
NOMESCO Finland
Implantation of permanent biventricular pacemaker, transvenous route
+∞
7.3
7
*
AS2
HP
Ventricular pacemaker insertion VVI (R)
6.8
7.3
17
25
ZX197
NOMESCO Finland
NA
15.8
7.2
11
7
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.4
7.2
20
37
Z49.0
ICD-10 Finland
Preparatory care for dialysis
4.3
7.2
25
59
WX730
NOMESCO Finland
Conventional respirator
3.4
7.2
32
94
N17.8
ICD-10 Finland
Other acute renal failure
4.6
7.2
23
50
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
7.2
73
346
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
7.2
417
3206
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.5
7.2
53
214
FN1BD
NOMESCO Finland
Extensive CT of coronary arteries
20.1
7.1
10
5
B01AF03
ATC
edoxaban; oral
3.4
7.1
32
95
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
7.1
128
750
FM1CD
NOMESCO Finland
Very extensive CT of heart
7.9
7.1
15
19
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
7.1
144
2181
N18.0
ICD-10 Finland
End-stage renal disease
4.0
7.1
26
65
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.2
7.1
35
112
AQ2
HP
Electrophysiological electroanatomical examination
8.8
7.0
14
16
FPH96
NOMESCO Finland
Other removal of cardiac pacemaker or cardioverter-defibrillator
8.8
7.0
14
16
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
7.0
84
428
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
6.9
103
568
J01FF01
ATC
clindamycin; systemic
1.4
6.9
432
3357
K22
ICPC
Risk factor cardiovascular disease
2.0
6.9
85
438
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
6.9
115
658
M01AB05
ATC
diclofenac; systemic, rectal
0.8
6.8
902
10240
SPAT1255
SPAT
Intravenous administration of medicine
1.8
6.8
107
600
RS221
NOMESCO Finland
NA
3.3
6.8
32
99
FPF00
NOMESCO Finland
Implantation of epicardial pacemaker with ventricular electrode
40.2
6.8
8
*
3A149
NOMESCO Finland
NA
40.2
6.8
8
*
A02BC02
ATC
pantoprazole; systemic
1.3
6.8
1040
9180
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.3
6.7
31
94
SPAT1097
SPAT
Recording of ECG
1.5
6.7
219
1504
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
22.6
6.7
9
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
6.6
436
3414
K29
ICPC
Cardiovascular sympt/complt other
2.2
6.6
65
306
EBA00
NOMESCO Finland
Extraction of tooth
1.3
6.5
524
4232
L04AA01
ATC
[U] ciclosporin; systemic
3.5
6.5
28
81
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
4.0
6.5
24
61
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
6.5
110
635
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
6.4
204
1389
4271A
ICD-9 Finland
Cardiac dysrhythmias, Paroxysmal ventricular tachycardia
70.1
6.4
7
*
ZXA05
NOMESCO Finland
Left side
1.4
6.4
391
3024
5253
FHL
Cardiac lung machine
14.3
6.4
10
7
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.3
6.4
57
255
V03AE01
ATC
polystyrene sulfonate; oral
3.9
6.4
24
62
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
6.4
109
629
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.4
452
3581
5CM18
NOMESCO Finland
NA
8.2
6.3
13
16
212
Kela drug reimbursment
Gout
2.5
6.3
45
180
I47.0
ICD-10 Finland
Re-entry ventricular arrhythmia
11.0
6.3
11
10
I44.0
ICD-10 Finland
Atrioventricular block, first degree
3.6
6.3
26
73
WW500
NOMESCO Finland
Blood transfusion
2.1
6.3
65
314
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
18.1
6.3
9
5
ATB
HP
Replacement of biventricular, physiological pacemaker DDD (R) S
+∞
6.3
6
*
AK1
HP
HTX (heart transplant)
+∞
6.3
6
*
K06.10
ICD-10 Finland
Gingival fibromatosis
+∞
6.3
6
*
XX3BW
NOMESCO Finland
NA
+∞
6.3
6
*
354
Kela drug reimbursment
Ivabradine
+∞
6.3
6
*
WX720
NOMESCO Finland
Own respiration
2.3
6.2
52
228
AS5
HP
Biventricular heart failure pacemaker insertion VVI (R)
26.7
6.2
8
*
I51.4
ICD-10 Finland
Myocarditis, unspecified
7.0
6.2
14
20
205
Kela drug reimbursment
Chronic hypertension
1.3
6.2
428
3373
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
6.2
163
1065
K01
ICPC
Heart pain
5.0
6.2
18
36
WW200
NOMESCO Finland
Immunization
2.4
6.2
48
203
I45.3
ICD-10 Finland
Trifascicular block
6.3
6.2
15
24
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
5.3
6.1
17
32
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
7.7
6.1
13
17
I95.2
ICD-10 Finland
Hypotension due to drugs
7.7
6.1
13
17
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
6.1
247
1773
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.0
6.1
22
55
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.9
6.1
23
60
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
6.0
99
564
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.3
6.0
53
239
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1666
4373
13.30
307.65
7.8
2.4
ng/l
1921.1
1135.5
7.93
1601
3615
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
720
1183
8.63
307.65
5.4
2.3
ng/l
327.0
133.6
16.84
692
1063
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
896
2147
6.42
307.65
3.3
2.4
%
23.7
24.1
0.33
812
1836
(3004789) Transferrin [Mass/volume] in Serum or Plasma
910
2291
6.14
307.65
3.3
2.3
g/l
2.3
2.3
2.78
878
2126
(3022948) Iron [Moles/volume] in Serum or Plasma
949
2460
6.10
307.65
3.3
2.4
umol/l
14.2
13.6
1.30
916
2282
(3027456) Digoxin [Moles/volume] in Serum or Plasma
221
258
9.43
176.85
3.0
2.7
nmol/l
0.8
0.8
0.78
179
200
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
272
427
7.14
169.03
1.8
2.1
mg/l
10.8
11.5
0.60
246
398
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
749
2951
3.36
144.39
5.1
2.9
ng/l
397.2
235.3
0.34
685
2291
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1222
6417
3.08
142.35
3.8
2.6
ug/l
197.6
169.4
0.66
1169
5886
(3032080) INR in Blood by Coagulation assay
1282
6939
3.09
140.96
18.8
8.2
inr
1.5
1.2
12.19
336
1960
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
891
3946
3.14
140.11
2.7
2.1
mg/l
2.7
2.9
1.17
794
3324
(3022217) INR in Platelet poor plasma by Coagulation assay
614
2212
3.48
135.69
42.1
22.8
inr
1.7
1.4
3.66
72
329
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
308
725
4.79
122.79
1.8
2.0
u/l
31.1
38.9
6.27
197
642
(3012095) Magnesium [Moles/volume] in Serum or Plasma
678
2775
3.10
119.17
7.4
3.5
mmol/l
0.8
0.8
0.03
646
2613
(3020779) Urea [Moles/volume] in Serum or Plasma
478
1585
3.59
118.73
18.1
7.0
mmol/l
11.5
9.4
6.32
466
1514
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1088
6214
2.51
94.68
4.9
2.8
ng/l
28.8
27.2
0.24
890
4355
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
230
567
4.42
85.52
8.0
3.0
u/ml
0.4
0.3
1.09
148
297
(3000991) Gas panel - Venous blood
396
1464
3.09
79.94
17.7
8.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
526
2279
2.73
79.10
10.4
5.9
mmol/l
1.1
1.0
6.14
495
2139
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1325
8873
2.28
72.67
9.5
6.7
umol/l
14.5
12.1
6.96
1277
8444
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
450
1924
2.69
68.49
14.8
7.6
kpa
5.1
5.2
0.51
429
1839
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
324
1162
3.10
68.30
2.7
1.9
ug/l
19.0
6.4
2.90
299
1009
(3027801) Oxygen [Partial pressure] in Arterial blood
449
1925
2.68
67.92
14.8
7.6
kpa
11.3
12.4
5.05
425
1841
(3002032) Base excess in Venous blood by calculation
393
1579
2.82
67.41
6.5
3.8
mmol/l
1.6
2.0
0.89
316
1271
(3003396) Base excess in Arterial blood by calculation
446
1921
2.67
66.74
14.9
7.6
mmol/l
0.7
0.9
0.61
358
1511
(3021447) Carbon dioxide [Partial pressure] in Venous blood
392
1581
2.81
66.70
6.5
3.8
kpa
5.9
5.8
0.33
377
1542
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1257
8492
2.15
64.00
13.3
6.8
mmol/l
1.2
1.2
8.91
1095
7155
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
249
791
3.43
63.95
4.2
3.5
pmol/l
4.3
4.5
1.40
235
704
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1171
7728
2.13
63.03
12.7
6.0
mmol/l
1.2
1.2
7.48
1101
6982
(3014111) Lactate [Moles/volume] in Serum or Plasma
377
1535
2.76
62.72
16.0
7.2
mmol/l
1.5
1.4
1.22
362
1480
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
252
830
3.31
60.98
7.5
4.2
mmol/l
23.9
24.2
0.85
234
754
(3023368) Bacteria identified in Blood by Culture
831
4860
2.15
60.86
5.6
4.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1248
8516
2.10
60.50
8.0
6.0
e9/l
0.6
0.6
4.19
1083
7295
(3013826) Glucose [Moles/volume] in Serum or Plasma
1415
10124
2.15
60.48
9.5
4.6
mmol/l
6.9
6.7
2.00
1369
9535
(3013115) Eosinophils [#/volume] in Blood
1281
8832
2.11
60.33
8.6
6.3
e9/l
0.2
0.2
0.56
1120
7677
(3016502) Oxygen saturation in Arterial blood
404
1740
2.63
59.93
16.1
7.9
%
94.9
95.7
1.44
392
1677
(3006315) Basophils [#/volume] in Blood
1249
8560
2.09
59.40
8.0
6.0
e9/l
0.0
0.0
0.16
1082
7337
(3019198) Lymphocytes [#/volume] in Blood
1267
8752
2.08
58.70
8.1
6.1
e9/l
1.8
1.9
2.07
1111
7627
(3026250) Tacrolimus [Mass/volume] in Blood
67
76
9.07
54.20
33.7
37.5
ug/l
7.7
7.2
1.31
60
69
(3024561) Albumin [Mass/volume] in Serum or Plasma
1100
7393
1.99
52.91
6.3
5.1
g/l
34.6
35.5
5.51
1045
6872
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
257
938
2.97
51.90
19.9
9.7
mmol/l
24.1
24.3
0.39
242
883
(3002173) Hemoglobin [Mass/volume] in Arterial blood
363
1600
2.53
50.70
17.5
8.4
g/l
123.8
123.7
0.03
354
1533
(42870588) Differential panel, method unspecified - Blood
924
5914
1.98
50.45
8.6
6.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1594
12340
2.11
50.00
7.0
3.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
450
2213
2.31
49.08
15.4
7.1
mmol/l
104.1
104.5
0.76
443
2165
(3022493) Free Hemoglobin [Mass/volume] in Plasma
55
55
10.24
48.79
35.4
1.7
mg/l
81.2
82.4
0.02
48
44
(3006504) Eosinophils/100 leukocytes in Blood
1153
8024
1.94
48.52
8.5
6.2
%
2.7
2.9
1.25
1111
7438
(3022096) Basophils/100 leukocytes in Blood
1129
7815
1.93
48.15
8.6
6.3
%
0.6
0.7
0.96
1086
7259
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
518
2722
2.19
47.95
2.1
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
803
4968
1.98
47.70
5.9
3.9
ph
7.4
7.4
0.58
145
964
(3019069) Monocytes/100 leukocytes in Blood
1155
8075
1.93
47.59
8.7
6.5
%
9.1
8.9
1.78
1114
7529
(3002030) Lymphocytes/100 leukocytes in Blood
1176
8274
1.93
47.50
8.6
6.3
%
24.4
27.5
18.34
1129
7669
(3033658) Prothrombin time (PT) actual/Normal
740
4481
1.99
46.51
6.6
4.2
%
73.3
88.8
33.77
726
4393
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
74
116
6.57
45.33
1.7
1.5
umol/l
15.1
12.8
1.76
74
106
(3042733) HLA Ab [Presence] in Serum
54
59
9.36
44.91
5.2
4.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
408
2005
2.28
44.15
10.0
4.6
u/l
261.4
237.6
1.55
389
1900
(3018010) Neutrophils/100 leukocytes in Blood
1149
8170
1.87
43.38
8.4
6.1
%
60.2
57.3
13.45
1105
7619
(3018677) aPTT in Platelet poor plasma by Coagulation assay
481
2547
2.14
43.13
7.1
2.0
s
31.7
29.8
5.89
470
2463
(3013650) Neutrophils [#/volume] in Blood by Automated count
1330
9919
1.89
43.03
11.1
9.6
e9/l
4.4
4.2
3.46
1157
8599
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1664
13390
2.06
42.71
11.4
7.7
u/l
80.1
79.0
0.41
1597
12625
(40758558) Short blood count panel - Blood
700
4267
1.95
42.36
9.9
7.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
599
3504
1.98
40.59
6.1
1.6
mg/l
1.7
1.4
0.94
494
2692
(3024471) HLA-A [Type]
52
62
8.57
40.42
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
51
61
8.54
39.54
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
207
776
2.84
39.48
1.7
1.8
g/l
1.6
1.5
0.71
180
673
(3024354) Oxygen [Partial pressure] in Venous blood
292
1303
2.44
39.12
5.9
3.3
kpa
4.8
4.6
0.39
277
1271
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
835
5512
1.84
38.68
3.8
3.4
u/l
48.7
38.0
0.75
795
5225
(3026493) Urate [Moles/volume] in Serum or Plasma
745
4777
1.85
37.67
3.7
2.7
umol/l
3184.9
5135.1
0.75
665
4161
(3020630) Protein [Mass/volume] in Serum or Plasma
313
1464
2.33
37.63
2.0
2.6
g/l
63.7
66.5
6.66
290
1328
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
368
1848
2.20
37.27
2.0
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
456
2486
2.06
37.26
2.7
2.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
227
926
2.62
36.67
23.5
10.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
152
499
3.20
36.57
7.2
2.6
g/l
3.7
3.6
0.25
146
473
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
367
1859
2.17
36.29
2.0
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1060
7660
1.75
35.08
12.5
9.4
e9/l
0.0
0.0
0.04
869
6270
(3010375) cycloSPORINE [Mass/volume] in Blood
53
78
6.94
34.42
23.3
28.7
ug/l
113.5
127.6
0.59
34
67
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
91
239
3.93
30.72
10.3
6.4
mg/l
10.8
11.2
0.37
86
222
(3045788) Cell count panel - Pleural fluid
72
159
4.65
30.46
1.6
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
110
332
3.44
30.27
1.6
1.3
u/ml
253.3
267.1
0.21
85
200
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
77
182
4.35
29.92
1.4
1.1
%
93.6
96.9
0.39
77
170
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
114
356
3.33
29.73
1.6
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
81
201
4.15
29.54
1.5
1.4
e6/l
14752.1
2613.8
0.46
53
145
(3027945) Reticulocytes/100 erythrocytes in Blood
359
1939
2.02
29.49
2.5
2.7
%
1.9
1.7
2.26
328
1712
(3019060) Gas panel - Arterial blood
231
1056
2.33
28.96
6.6
5.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
73
170
4.41
28.91
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
250
1184
2.26
28.83
6.4
3.9
ng/l
125.4
87.1
4.20
230
1040
(3024928) Oxygen saturation in Venous blood
112
357
3.25
28.25
6.8
2.8
—
—
—
0
0
(3036489) Thrombin time
163
644
2.66
27.93
7.2
2.1
s
22.4
21.3
1.42
158
568
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
323
1713
2.04
27.80
2.3
2.4
g/l
0.2
0.2
2.11
296
1603
(3003434) Protein [Mass/volume] in Pleural fluid
83
220
3.88
27.67
1.4
1.4
g/l
27.0
33.8
4.56
66
201
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
731
5004
1.70
27.56
2.6
2.1
u/l
215.6
232.8
0.19
703
4721
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
72
173
4.27
27.40
2.4
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
71
169
4.31
27.35
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
37
47
7.99
27.29
1.2
1.7
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
27
22
12.42
27.26
1.2
1.0
ng/l
65.0
73.2
0.06
22
16
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
109
352
3.21
26.91
1.8
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
153
597
2.68
26.86
5.1
2.1
ug/l
547.1
432.6
0.31
148
563
(3028308) Erythrocytes [#/volume] in Pleural fluid
73
184
4.07
26.09
1.5
1.4
e6/l
26044.8
95099.1
1.12
43
112
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
85
244
3.59
25.26
1.5
1.2
u/ml
3.0
4.3
0.95
44
107
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
100
319
3.24
25.20
1.9
1.4
u/ml
118.6
118.0
0.01
12
58
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
73
192
3.90
24.62
1.1
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
215
1020
2.23
24.57
6.1
3.0
g/l
131.6
132.0
0.09
206
998
(3009445) Proteinase 3 Ab [Units/volume] in Serum
174
754
2.42
24.53
1.6
1.5
u/ml
13.1
23.2
—
7
21
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
84
248
3.48
23.93
1.4
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
340
1928
1.91
23.88
2.9
3.2
umol/l
9.8
9.1
0.27
306
1724
(3048929) Epstein Barr virus Ab [Presence] in Serum
126
477
2.74
23.44
1.5
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
357
2069
1.87
23.40
1.3
1.3
titre
464.3
487.0
0.08
61
407
(4306422)
82
242
3.48
23.38
1.5
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1472
12282
1.62
23.30
4.3
3.5
pmol/l
15.3
14.8
10.19
1370
11035
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
82
248
3.40
22.51
1.5
1.2
u/ml
2.7
3.8
0.31
31
88
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
105
374
2.90
21.89
9.9
6.3
iu/ml
997.0
4582.9
0.42
24
55
(3023183) Ammonium ion [Moles/volume] in Plasma
113
419
2.79
21.87
2.3
3.2
umol/l
32.3
38.5
1.20
99
356
(3002582) Erythrocytes [#/volume] in Urine
744
5392
1.58
20.99
3.7
3.3
e6/l
103.4
89.2
0.14
581
4180
(3012441) Differential panel - Pleural fluid
66
182
3.71
20.84
1.4
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
431
6420
0.59
20.81
3.0
2.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
207
1032
2.11
20.79
1.8
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
229
1188
2.04
20.67
1.6
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
334
1967
1.83
20.62
2.3
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
219
1130
2.04
20.05
5.5
4.0
mmol/l
1.8
1.7
0.18
158
829
(3030467) Casts [#/volume] in Urine by Automated count
683
4898
1.58
19.95
3.6
3.2
e6/l
0.6
0.4
1.01
520
3701
(3044640) Blood type and Crossmatch panel - Blood
735
5376
1.56
19.61
3.2
2.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
153
691
2.31
19.60
2.3
1.9
ug/l
11.6
3.7
0.40
138
606
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
43
90
4.85
19.44
1.2
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
116
465
2.58
19.28
5.3
3.2
—
—
—
0
0
(4268621)
60
164
3.73
19.20
3.2
2.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1736
15362
1.66
19.07
5.3
4.1
mu/l
2.0
2.2
0.61
1625
13887
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
593
4156
1.59
18.94
3.1
2.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1912
17392
1.87
18.89
25.9
13.6
mg/l
25.2
25.9
0.40
1704
13691
(3009343) pH of Capillary blood
221
1169
1.99
18.85
5.6
4.1
ph
7.4
7.4
0.34
28
124
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
94
343
2.82
18.77
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
94
343
2.82
18.77
1.3
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
223
1187
1.98
18.68
5.6
4.0
kpa
5.2
5.1
0.10
212
1099
(3008152) Bicarbonate [Moles/volume] in Arterial blood
199
1019
2.05
18.57
10.3
7.0
mmol/l
24.4
24.6
0.26
185
944
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
120
500
2.48
18.40
1.2
1.3
—
9.0
—
0
7
(3019550) Sodium [Moles/volume] in Serum or Plasma
1981
18266
2.03
18.27
36.3
15.3
mmol/l
139.5
139.7
4.56
1959
17798
(3017143) Hepatitis C virus Ab [Presence] in Serum
294
1725
1.82
18.25
1.9
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
165
794
2.17
18.12
4.4
3.2
mmol/l
24.6
25.1
1.07
158
772
(3009508) Creatinine [Moles/volume] in Urine
744
5531
1.53
18.09
3.7
3.3
mmol/l
7.4
8.2
6.22
643
4631
(3034426) Prothrombin time (PT)
33
58
5.76
18.06
1.7
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
30
48
6.32
18.02
1.1
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
314
1890
1.77
17.87
1.9
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
658
4780
1.54
17.72
3.5
3.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
709
5237
1.53
17.67
3.7
3.3
mg/l
85.3
314.7
4.22
505
3415
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
119
505
2.44
17.55
1.8
2.2
g/l
0.0
0.0
1.00
106
463
(3018095) Leukocytes [#/volume] in Urine
804
6115
1.50
17.36
4.4
3.7
e6/l
127.8
85.8
0.48
597
4466
(3023103) Potassium [Moles/volume] in Serum or Plasma
1981
18329
1.98
17.11
36.8
15.4
mmol/l
4.1
4.0
37.03
1960
17833
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
137
629
2.26
16.88
1.7
2.3
g/l
3.1
3.1
0.01
115
503
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
143
669
2.22
16.84
1.7
2.3
g/l
3.7
3.8
0.24
113
488
(3023520) Reticulocytes [#/volume] in Blood
255
1467
1.84
16.82
2.3
2.9
e9/l
72.3
67.2
1.08
179
1133
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
143
670
2.21
16.78
1.7
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
143
671
2.21
16.72
1.7
2.3
g/l
7.2
7.3
0.20
116
512
(46235355) HIV 1 and 2 tests - Meaningful Use set
366
2352
1.67
16.33
2.0
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
136
632
2.23
16.28
1.7
2.3
g/l
9.9
10.4
0.66
121
538
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
110
468
2.42
16.14
1.8
2.2
g/l
0.0
0.0
0.00
98
433
(3043409) Potassium [Moles/volume] in Arterial blood
112
481
2.40
16.10
5.5
4.3
mmol/l
4.1
3.9
3.09
106
453
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
428
2871
1.61
16.08
3.2
3.1
e6/l
2.7
1.5
1.26
217
1550
(3020682) Albumin/Creatinine [Ratio] in Urine
730
5509
1.49
16.07
4.5
4.0
mg/mmol
13.6
9.0
1.56
519
3584
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
111
476
2.40
16.01
1.8
2.2
g/l
0.0
0.0
0.00
98
434
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
989
7927
1.46
15.96
4.5
4.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
556
3976
1.54
15.77
1.7
1.5
nmol/l
19.3
20.5
1.22
502
3368
(40768806) Pleura Pathology biopsy report
59
183
3.29
15.63
1.6
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
267
1591
1.77
15.63
2.2
2.6
u/l
41.4
69.8
0.46
230
1376
(3021879) Hepatitis B virus core Ab [Presence] in Serum
207
1141
1.90
15.58
1.6
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
21
27
7.84
15.30
6.8
6.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
27
46
5.93
15.26
1.1
1.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
55
166
3.37
15.22
1.3
1.3
mmol/l
5.7
6.3
0.69
49
151
(3000850) Epithelial cells [#/volume] in Urine
523
3718
1.54
15.16
2.9
2.5
e6/l
4.5
4.4
0.05
465
3289
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
885
6997
1.45
15.09
2.1
1.9
pmol/l
94.4
94.3
0.03
515
3770
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
702
5316
1.47
14.95
3.3
2.6
u/l
60.5
59.2
0.20
668
4906
(3031040) Bacteria [#/volume] in Urine by Automated count
1287
10922
1.44
14.82
4.6
4.1
e6/l
402.9
1999.8
1.14
20
156
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
442
3043
1.57
14.74
3.1
2.9
e6/l
1.2
0.9
0.48
231
1715
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
111
495
2.31
14.66
6.2
4.1
mg/l
1.8
1.5
4.29
103
457
(3020891) Body temperature
135
655
2.13
14.52
5.5
4.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
124
583
2.20
14.44
1.8
2.5
g/l
0.2
1.3
4.23
108
502
(3022313) Gas panel - Capillary blood
168
887
1.97
14.36
6.2
4.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
116
535
2.23
14.16
1.8
2.1
g/l
35.8
37.7
2.18
99
457
(3013512) EKG study
669
5078
1.46
13.86
6.6
3.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
180
989
1.89
13.66
1.4
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
591
4389
1.48
13.66
2.9
3.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
19
25
7.66
13.57
5.6
6.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
113
526
2.21
13.49
1.7
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
102
455
2.30
13.48
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
86
363
2.43
12.88
1.8
2.2
g/l
137.4
130.1
1.40
50
248
(3004588) Protein electrophoresis panel - Serum or Plasma
208
1219
1.78
12.82
1.8
2.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
96
429
2.30
12.65
1.6
2.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
98
442
2.28
12.64
1.6
1.5
g/l
1.2
1.2
0.19
90
420
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
95
426
2.29
12.42
1.6
1.5
g/l
0.2
0.2
0.49
86
407
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
42
123
3.46
12.22
1.3
1.3
u/l
18.1
12.6
0.19
34
114
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
102
475
2.20
12.19
1.5
1.3
—
—
—
0
0
(3010421) pH of Blood
97
450
2.21
11.71
3.4
4.2
ph
7.4
7.4
0.02
83
363
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
42
127
3.35
11.65
1.5
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
84
368
2.33
11.61
3.5
4.5
mmol/l
2.1
2.6
0.98
52
255
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
32
81
4.00
11.48
1.7
2.0
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
11
0
+∞
11.47
1.3
0.0
ng/l
42.7
—
—
11
0
(3026782) Osmolality of Urine
476
3493
1.47
11.40
3.0
2.7
mosm/kgh2o
538.7
574.7
3.19
414
2994
(3051611) Lipemic interference index of Serum or Plasma
46
150
3.11
11.30
7.0
3.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
75
1618
0.44
11.22
1.4
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
90
415
2.22
11.04
1.6
2.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
24
50
4.84
10.96
1.7
2.3
e6/l
6022.5
1138.3
1.86
16
32
(40767503) Oxygen content in Capillary blood by calculation
79
346
2.33
10.94
2.1
2.5
%
17.3
16.3
0.90
38
181
(3015377) Calcium [Moles/volume] in Serum or Plasma
715
5682
1.39
10.87
3.9
3.5
mmol/l
2.3
2.3
1.53
624
4930
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
110
553
2.04
10.82
2.0
3.5
mg/l
30.0
65.2
0.90
92
443
(3034860) Kappa light chains.free [Mass/volume] in Serum
110
553
2.04
10.82
2.0
3.5
mg/l
52.9
59.1
0.18
94
441
(3013707) Erythrocyte sedimentation rate by Westergren method
1431
12695
1.38
10.76
5.0
3.9
mm/h
14.7
11.6
10.21
1352
11720
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
141
779
1.87
10.54
7.0
4.5
mmol/l
24.6
24.8
0.23
135
729
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
218
1366
1.66
10.53
3.1
2.5
ml/min/173m2
57.6
67.0
3.19
95
525
(3033799) Differential panel - Peritoneal fluid
24
52
4.66
10.48
2.5
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
119
623
1.96
10.45
2.9
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
133
723
1.89
10.45
2.2
2.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
10
0
+∞
10.42
1.2
0.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1810
16778
1.49
10.24
25.7
12.7
ml/min/173m2
74.8
80.9
21.03
1630
13861
(21494755) Public health laboratory ask at order entry panel
87
1717
0.49
10.15
1.4
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
106
541
2.01
10.02
2.0
3.4
ratio
1.6
2.9
—
6
48
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
83
386
2.20
10.00
1.6
1.6
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
13
9.28
9.87
2.1
2.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
33
96
3.48
9.75
7.2
3.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
60
248
2.46
9.48
1.6
1.8
mmol/l
1.7
1.6
0.42
60
241
(3024891) Influenza virus A+B Ag [Presence] in Specimen
86
416
2.11
9.40
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1576
14337
1.37
9.21
32.1
16.6
%
14.1
13.6
21.06
1554
13991
(3019309) Folate [Moles/volume] in Red Blood Cells
420
3123
1.43
9.17
1.8
1.7
nmol/l
1183.7
1146.7
0.32
337
2324
(3015235) Bicarbonate [Moles/volume] in Capillary blood
89
441
2.06
9.14
3.2
3.1
mmol/l
24.2
24.9
0.61
82
378
(3042010) Triglyceride [Moles/volume] in Pleural fluid
16
28
5.75
8.80
1.4
1.1
mmol/l
1.0
1.1
—
8
22
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1759
16336
1.41
8.75
6.8
5.5
mmol/mol
41.4
39.6
11.92
1667
15048
(3021901) Oxygen saturation in Capillary blood
68
310
2.23
8.64
2.5
2.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
119
666
1.83
8.58
2.1
1.8
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
14
22
6.40
8.53
1.4
1.1
u/l
30.6
54.2
—
7
16
(3037467) Urinalysis macro (dipstick) panel - Urine
1311
11674
1.31
8.43
4.8
4.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
45
1059
0.41
8.39
1.2
1.5
—
—
—
0
0
(44790047)
49
199
2.50
8.08
1.5
1.8
—
—
—
0
0
(44790048)
49
199
2.50
8.08
1.5
1.8
—
—
—
0
0
(44790049)
49
199
2.50
8.08
1.5
1.8
—
—
—
0
0
(44806118)
49
199
2.50
8.08
1.5
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
93
490
1.94
8.08
1.4
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
13
20
6.53
8.07
1.8
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
72
347
2.11
7.99
1.5
1.8
iu/l
210.5
5.7
0.47
15
116
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
20
47
4.29
7.94
1.5
1.4
%
28.6
27.1
0.07
13
39
(3036481) Cortisol [Moles/volume] in Serum or Plasma
219
1472
1.54
7.88
2.7
2.4
nmol/l
393.8
367.8
1.10
209
1362
(3011397) Hemoglobin [Presence] in Urine by Test strip
482
3767
1.36
7.69
3.8
3.3
—
—
—
0
0
(3035880) pH of Pleural fluid
29
91
3.22
7.67
1.3
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
66
320
2.10
7.24
1.7
2.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
10
5
20.08
7.13
4.9
9.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
85
454
1.91
7.13
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
46
195
2.39
6.97
1.6
2.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
31
4.87
6.93
3.4
5.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
74
381
1.98
6.92
3.4
3.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
12
20
6.03
6.90
7.5
10.8
mmol/l
4.6
6.7
2.03
12
20
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
63
307
2.08
6.84
1.3
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
25
77
3.27
6.83
1.9
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
47
205
2.32
6.69
1.7
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
84
458
1.87
6.64
1.2
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
50
225
2.25
6.63
1.7
1.9
ug/l
17.4
25.8
0.83
50
225
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
83
452
1.87
6.59
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
27
90
3.03
6.50
1.7
2.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
27
90
3.03
6.50
1.7
2.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
27
90
3.03
6.50
1.7
2.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
27
90
3.03
6.50
1.7
2.7
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
14
29
4.85
6.45
1.4
1.1
mmol/l
1.7
1.9
—
7
19
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
54
254
2.15
6.44
1.4
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
83
459
1.84
6.29
1.1
1.3
titre
70.0
86.7
—
10
43
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
42
183
2.32
6.03
1.7
2.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
54
262
2.09
5.97
1.1
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
770
6597
1.26
5.95
2.6
2.2
nmol/l
74.0
76.8
1.82
701
5875
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
87
2.90
5.62
1.5
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
87
2.90
5.62
1.5
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
196
1385
1.46
5.56
4.4
3.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
191
1345
1.46
5.52
2.8
2.8
g/l
10.9
10.7
0.20
182
1225
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
662
7712
0.80
5.51
3.4
4.1
%
24.1
21.4
3.66
298
3746
(3025941) Bacteria identified in Stool by Culture
130
844
1.57
5.50
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
36
153
2.38
5.49
1.5
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
36
153
2.38
5.49
1.5
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
36
153
2.38
5.49
1.5
2.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1909
18277
1.38
5.46
23.0
12.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
85
497
1.74
5.40
10.4
6.3
mmol/l
1.4
1.3
0.22
75
429
(4010399)
176
1225
1.48
5.40
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
304
2333
1.35
5.34
1.8
1.9
%
1.6
1.5
2.14
257
2054
(3000475) Leukocytes [#/volume] in Synovial fluid
77
440
1.78
5.30
1.6
1.6
e6/l
23768.0
15007.5
0.40
51
304
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
108
677
1.63
5.30
8.5
5.3
%
1.7
1.7
0.28
101
634
(3021788) Differential panel - Synovial fluid
62
332
1.89
5.25
1.3
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
44
3.66
5.20
1.2
2.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
70
3.02
5.10
2.3
3.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
57
300
1.92
5.09
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
110
700
1.60
5.09
1.3
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
10
19
5.28
5.04
5.8
6.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
62
337
1.86
5.03
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
44
212
2.10
5.01
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
104
664
1.59
4.76
8.7
5.4
%
0.9
0.9
0.22
96
622
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
69
396
1.77
4.71
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
158
2193
0.70
4.52
2.5
2.3
nmol/l
11.9
13.6
1.71
137
1957
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
249
1.95
4.50
1.3
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
20
70
2.87
4.49
17.1
12.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
53
285
1.88
4.48
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
53
285
1.88
4.48
1.5
1.3
mmol/l
57.2
64.1
0.56
39
234
(21494890) Protein electrophoresis panel - 24 hour Urine
36
169
2.15
4.41
1.4
2.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
31
649
0.47
4.39
1.7
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
16
50
3.22
4.33
2.6
2.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
147
1039
1.45
4.21
1.6
2.0
g/l
1.2
1.5
1.06
139
948
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1789
17097
1.27
4.21
5.3
4.4
mmol/l
6.3
6.0
16.93
1651
15471
(3044941) Cell count panel - Synovial fluid
53
293
1.83
4.13
1.2
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
71
428
1.68
4.12
2.1
3.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
12
32
3.77
4.08
1.5
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1755
16756
1.25
4.02
4.6
3.8
mmol/l
1.5
1.3
13.33
1649
15227
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
47
253
1.88
3.99
4.0
2.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
319
2567
1.28
3.98
1.2
1.2
iu/ml
72.1
29.9
1.54
84
786
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
63
372
1.71
3.95
1.5
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
864
9578
0.84
3.94
3.9
4.9
ug/l
2.6
3.5
1.04
767
8642
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
237
1838
1.33
3.89
4.1
3.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
33
158
2.11
3.88
1.3
1.3
g/l
7.9
6.7
0.93
25
113
(40768800) Prostate Pathology biopsy report
33
646
0.50
3.88
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
376
3103
1.26
3.81
3.0
3.2
mmol/l
2.5
2.4
0.36
327
2742
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
67
408
1.66
3.77
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
221
1705
1.33
3.76
1.5
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
40
209
1.93
3.73
3.1
4.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
69
425
1.64
3.72
1.6
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
494
5745
0.82
3.71
2.6
3.0
ug/l
0.8
0.8
0.42
363
3764
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
9
7.80
3.56
1.6
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
9
7.80
3.56
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
41
727
0.56
3.52
1.4
1.7
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
32
158
2.04
3.51
1.3
1.3
g/l
3.3
2.9
0.52
24
113
(4062490)
32
158
2.04
3.51
1.3
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
32
158
2.04
3.51
1.3
1.3
g/l
0.6
0.4
1.50
24
112
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
47
265
1.79
3.49
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
273
2191
1.28
3.48
13.5
6.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
27
125
2.17
3.48
1.7
2.6
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
10
7.02
3.36
2.7
4.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
15
53
2.84
3.35
2.6
1.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
30
148
2.04
3.31
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
38
204
1.88
3.31
1.3
1.6
%
60.1
59.0
0.05
23
130
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
31
156
2.00
3.25
1.7
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
42
235
1.80
3.22
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
228
1808
1.29
3.20
6.7
4.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
89
608
1.48
3.11
4.5
3.6
g/l
0.4
0.3
0.56
52
282
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1812
17475
1.23
3.11
5.0
4.2
mmol/l
4.4
4.7
38.34
1716
16087
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
139
2.03
3.06
1.5
2.7
%
15.7
13.6
0.20
15
65
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
8
7.52
3.05
1.0
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
8
7.52
3.05
1.0
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
179
1383
1.32
3.05
4.5
3.9
mmol/l
1.2
1.2
1.74
166
1211
(3018572) Chloride [Moles/volume] in Blood
57
354
1.63
3.03
13.6
7.4
mmol/l
104.6
105.1
0.22
50
312
(3039000) Anion gap in Blood
57
354
1.63
3.03
13.6
7.4
mmol/l
11.7
11.3
0.32
50
312
(3021440) Promyelocytes/100 leukocytes in Blood
178
1376
1.32
3.03
3.5
4.5
%
0.1
0.1
0.43
57
419
(4035726)
203
1598
1.30
3.02
2.0
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
41
233
1.77
3.01
1.3
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
44
256
1.73
2.98
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
186
1450
1.31
2.98
3.6
4.5
%
0.7
0.9
0.59
60
450
(3049233) Organic acids panel - Urine
5
5
10.02
2.98
1.2
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
69
2.48
2.96
1.8
3.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
69
2.48
2.96
1.8
3.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
28
141
2.00
2.95
1.7
2.7
%
71.1
72.1
0.10
28
136
(3000494) Fungus identified in Specimen by Culture
262
2140
1.26
2.91
1.8
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
14
52
2.70
2.89
1.1
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
70
2.44
2.88
1.8
3.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
31
164
1.90
2.85
1.5
1.3
e6/l
29291.5
84325.4
0.68
21
119
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1797
17351
1.21
2.84
4.9
4.2
mmol/l
1.3
1.4
36.94
1690
15875
(3021601) Nitrite [Presence] in Urine by Test strip
891
8164
1.16
2.76
5.1
4.5
estimate
0.0
0.0
0.50
169
1576
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1940
18896
1.26
2.74
16.1
10.1
u/l
29.7
28.2
1.54
1895
18193
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1258
11820
1.15
2.73
4.0
3.2
u/l
74.3
54.0
5.96
1181
11004
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
66
2.43
2.71
2.1
2.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
10
6.01
2.70
1.2
1.3
—
—
—
0
0
(3015736) pH of Urine
696
6270
1.16
2.69
3.6
3.1
—
5.5
—
0
8
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
19
4.22
2.68
1.8
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
48
296
1.64
2.66
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
117
867
1.37
2.66
1.4
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
899
8258
1.15
2.66
3.8
3.3
estimate
0.0
0.0
1.23
160
1489
(3045414) Leukocytes [Presence] in Urine
101
733
1.40
2.61
2.1
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
38
222
1.72
2.58
2.1
2.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
29
157
1.86
2.52
1.1
1.2
u/l
211.2
64.8
0.65
21
106
(3027923) C peptide [Moles/volume] in Serum or Plasma
19
88
2.17
2.51
1.2
1.3
nmol/l
1.7
1.2
0.71
14
66
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
21
3.82
2.46
3.4
1.7
ng/l
110.3
170.2
—
8
21
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
13
51
2.56
2.44
1.1
1.1
%
57.1
86.8
—
8
32
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
98
1321
0.73
2.43
1.4
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
96
2.09
2.43
1.2
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
42
257
1.65
2.43
2.1
2.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
43
265
1.64
2.42
1.4
1.7
g/l
0.8
0.9
0.11
36
210
(3025315) Body weight
6
12
5.01
2.40
4.3
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
37
220
1.69
2.38
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
205
1.72
2.38
1.2
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
168
1335
1.28
2.37
3.7
4.3
%
0.8
0.7
0.19
44
333
(3025159) Blasts/100 leukocytes in Blood
163
1291
1.28
2.37
3.6
4.6
%
0.0
0.5
1.01
51
345
(3006245) CD3-CD19+ cells/100 cells in Blood
16
71
2.26
2.34
2.0
2.9
%
7.4
10.7
0.69
16
66
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
206
1.71
2.34
1.2
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
206
1.71
2.34
1.2
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1544
14795
1.15
2.34
36.1
17.2
g/l
330.7
333.8
32.10
1532
14682
(3030905) Polymorphonuclear cells [#/volume] in Blood
51
331
1.55
2.33
2.8
3.7
e9/l
5.0
4.2
0.94
51
331
(3047007) Chlamydophila sp Ab [Presence] in Serum
36
214
1.69
2.33
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
883
8157
1.14
2.32
3.8
3.3
estimate
0.0
0.0
0.00
166
1543
(3007164) IgA [Mass/volume] in Serum or Plasma
352
3038
1.19
2.29
1.4
1.5
g/l
2.9
2.6
1.51
221
1862
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
15
66
2.28
2.24
1.1
1.4
%
52.5
59.6
—
8
57
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
209
1.69
2.23
1.2
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
29
165
1.77
2.19
4.2
2.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
35
211
1.67
2.17
1.2
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
47
306
1.55
2.14
2.4
3.9
%
2.0
1.5
0.35
40
232
(3011412) CD3 cells [#/volume] in Blood
32
189
1.70
2.14
2.2
2.9
e9/l
1.1
1.1
0.01
24
106
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
51
339
1.52
2.12
3.1
4.1
%
62.2
57.9
1.48
51
339
(3004451) EKG impression Narrative
13
55
2.37
2.12
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
20
102
1.97
2.10
3.0
2.8
ph
7.4
7.4
—
7
40
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
37
2.71
2.10
1.7
2.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
14
62
2.27
2.07
1.3
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
31
2.91
2.07
1.4
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
10
5.01
2.07
1.2
1.2
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
5
10
5.01
2.07
1.2
1.2
umol/l
105.6
78.0
—
5
10
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
30
176
1.71
2.06
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
67
474
1.43
2.06
1.3
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
96
1.99
2.05
1.2
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1834
17855
1.18
2.05
5.5
4.6
mmol/l
2.6
2.8
28.23
1731
16335
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
63
441
1.44
2.05
2.3
2.3
ug/min
98.6
100.9
0.02
36
268
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
56
2.33
2.05
1.8
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
69
492
1.42
2.03
1.4
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
32
192
1.68
2.03
1.5
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
21
3.34
1.96
1.6
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
121
952
1.29
1.90
1.4
1.3
u/ml
194.6
266.3
0.73
115
871
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
49
333
1.48
1.87
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
525
4745
1.14
1.87
1.3
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
18
93
1.94
1.85
1.7
2.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
17
3.54
1.84
1.2
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
33
207
1.60
1.80
1.2
1.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
33
207
1.60
1.80
1.5
1.3
nmol/l
0.2
0.4
—
10
18
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
36
231
1.57
1.79
1.2
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
414
3692
1.15
1.79
4.8
4.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
95
1.90
1.75
1.8
1.7
u/l
3.6
6.4
0.59
11
47
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
54
2.23
1.74
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
132
1.75
1.73
1.4
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
56
398
1.42
1.72
2.8
1.7
nmol/l
1.3
0.8
3.92
48
333
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
30
188
1.60
1.66
1.1
1.4
pmol/l
349.8
275.5
0.44
21
152
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
196
1.59
1.66
2.5
4.1
%
63.0
53.8
1.75
24
124
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
142
1.70
1.64
1.1
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
14
69
2.04
1.64
1.1
1.1
iu/ml
159.0
195.9
0.29
14
69
(3042111) Morphology [Interpretation] in Bone marrow Narrative
44
302
1.47
1.63
1.8
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
486
4412
1.13
1.61
4.1
3.6
estimate
0.0
0.0
0.33
153
1482
(3014051) Protein [Presence] in Urine by Test strip
49
345
1.43
1.60
2.5
2.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
32
2.51
1.59
1.6
1.1
%
119.5
97.7
—
8
32
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
32
2.51
1.59
1.6
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
69
517
1.35
1.57
1.5
1.6
iu/ml
0.1
1.8
0.55
12
90
(3008536) Aspergillus sp Ab [Presence] in Serum
11
50
2.21
1.57
1.2
2.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
71
537
1.33
1.53
1.3
1.2
u/ml
0.1
0.7
—
6
41
(3008898) HLA-B27 [Presence]
35
515
0.67
1.53
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
100
1.81
1.53
1.3
1.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
7
27
2.60
1.51
1.9
2.3
mmol/l
1.2
1.2
—
7
27
(4281824)
21
123
1.71
1.51
1.7
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
21
2.86
1.50
1.3
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
6
21
2.86
1.50
1.0
1.3
mmol/l
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
23
139
1.66
1.48
2.2
3.1
e6/l
378.3
602.4
1.55
16
121
(3000570) Elastase.pancreatic [Mass/mass] in Stool
65
489
1.34
1.46
1.4
1.4
ug/g
265.5
270.2
0.06
43
295
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
219
1.51
1.46
1.8
2.4
u/l
660.2
2819.6
0.83
14
80
(3025130) Human papilloma virus identified in Specimen
16
87
1.85
1.46
1.6
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
38
2.37
1.45
1.6
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
49
353
1.40
1.44
1.2
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
59
2.04
1.43
2.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
17
95
1.80
1.43
2.1
2.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
79
614
1.30
1.42
4.7
1.7
mg/l
8.6
4.3
1.17
71
445
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
49
354
1.39
1.42
1.1
1.3
miu/ml
193.2
215.0
0.17
13
152
(1002224) Polysomnography panel
57
759
0.74
1.41
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
81
1.86
1.40
1.2
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
81
1.86
1.40
1.2
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
40
2.26
1.40
1.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
10
46
2.18
1.40
1.3
1.5
pmol/l
19.4
14.4
—
10
39
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
29
2.42
1.39
2.9
2.2
—
—
—
0
0
(4094501)
32
466
0.68
1.35
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
19
112
1.70
1.35
1.4
1.2
mmol/l
9.4
12.3
—
7
38
(3041096) Erythrocytes [Presence] in Urine by Automated
410
4501
0.89
1.35
3.4
3.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
93
745
1.26
1.34
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
50
372
1.35
1.24
1.4
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
32
220
1.46
1.23
2.0
3.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
24
155
1.55
1.23
1.5
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
33
229
1.45
1.22
1.8
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
101
1.69
1.19
1.4
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
27
181
1.50
1.18
1.1
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
99
816
1.22
1.14
2.7
2.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
124
1046
1.20
1.13
2.7
2.8
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
65
1.85
1.13
2.3
1.5
—
1075525.0
—
0
6
(21494814) CD8 cells/100 lymphocytes in Specimen
13
73
1.79
1.11
1.5
2.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
104
1.64
1.09
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
272
2445
1.13
1.08
1.2
1.2
u/ml
16.6
11.6
0.48
104
950
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
97
1.65
1.06
1.5
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
145
1.52
1.06
1.4
1.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
21
137
1.54
1.05
1.6
1.4
—
77.1
—
0
10
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
33
2.12
1.05
1.7
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
170
1.48
1.04
1.4
1.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
22
2.28
1.03
2.0
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
22
2.28
1.03
2.0
1.5
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
22
2.28
1.03
2.0
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
16
98
1.64
1.03
2.4
2.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
122
1.56
1.02
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
44
575
0.76
1.02
2.1
1.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
55
431
1.28
1.00
1.1
1.2
—
39.2
—
0
17
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
29
0.00
0.97
0.0
1.1
—
53.2
—
0
29
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
11
187
0.59
0.97
3.7
3.9
u/ml
27.7
32.0
0.12
11
182
(3014271) Vancomycin [Susceptibility]
15
92
1.63
0.97
3.1
2.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
116
1.56
0.96
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
116
1.56
0.96
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
116
1.56
0.96
1.4
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
24
167
1.44
0.92
1.1
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
126
1.51
0.91
2.4
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
168
1.43
0.89
1.0
1.4
%
36.0
28.6
0.54
16
106
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
105
0.47
0.88
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
105
0.47
0.88
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
105
0.47
0.88
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
105
0.47
0.88
1.2
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
28
203
1.38
0.87
4.0
3.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
43
1.86
0.87
1.3
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
1987
19660
1.13
0.86
38.1
19.8
pg
30.5
30.5
0.72
1966
19345
(3024731) MCV [Entitic volume]
1987
19661
1.13
0.85
38.2
19.8
fl
92.3
91.1
21.43
1966
19348
(3007461) Platelets [#/volume] in Blood
1986
19651
1.13
0.85
38.3
19.9
e9/l
231.2
243.4
13.83
1952
19118
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
15
96
1.57
0.84
2.4
2.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
259
2362
1.11
0.84
1.2
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1987
19663
1.13
0.84
38.3
19.8
e12/l
4.5
4.6
12.82
1954
19069
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
59
721
0.81
0.83
3.5
3.6
u/ml
1003.1
3651.6
0.76
47
619
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
113
0.53
0.83
1.2
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
113
1302
0.86
0.83
1.4
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1987
19667
1.13
0.82
38.3
19.9
e9/l
7.1
6.7
10.72
1955
19064
(4198724)
12
73
1.65
0.81
2.2
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1987
19668
1.13
0.81
38.5
20.0
g/l
135.7
138.6
12.56
1967
19351
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
259
0.69
0.80
1.4
1.1
u/ml
0.4
2.0
—
9
112
(3019420) Tryptase [Mass/volume] in Serum or Plasma
11
66
1.67
0.78
1.8
1.4
ug/l
14.6
9.0
0.40
11
60
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1049
10147
1.07
0.78
2.6
2.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
126
0.55
0.77
1.1
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
200
1.35
0.76
3.9
2.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
53
1.70
0.75
1.6
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
75
1.60
0.75
1.1
1.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
54
1.67
0.74
3.9
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
54
1.67
0.74
3.9
2.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
19
133
1.43
0.73
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
87
1011
0.85
0.73
1.2
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
133
0.60
0.73
1.4
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
185
1.36
0.72
1.5
1.3
nmol/l
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
12
76
1.58
0.71
2.3
2.2
nmol/l
161.7
139.0
0.33
12
66
(3024263) Appearance of Synovial fluid
16
109
1.47
0.71
1.1
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
170
0.65
0.70
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
41
1.71
0.70
1.4
1.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
29
376
0.77
0.69
5.3
2.7
mg/l
23.8
28.7
0.51
20
216
(3029075) Extractable nuclear Ab panel - Serum
9
58
1.55
0.69
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
355
3322
1.08
0.68
1.2
1.2
u/ml
2.1
2.1
0.03
70
842
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
27
1.85
0.68
1.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
92
0.54
0.67
1.2
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
94
0.53
0.66
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
50
412
1.22
0.66
1.1
1.2
u/ml
2.0
8.2
—
10
52
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
282
0.74
0.65
1.3
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
103
1.46
0.65
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
95
1.48
0.64
1.3
1.8
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
8
129
0.62
0.64
1.0
1.1
mg/l
28.9
45.5
—
8
109
(3017732) Neutrophils [#/volume] in Blood
131
1173
1.12
0.63
2.9
3.3
e9/l
4.6
4.1
1.83
99
898
(3044927) Protein electrophoresis panel - Urine
25
190
1.32
0.62
1.1
1.1
—
—
—
0
0
(4034850)
64
544
1.18
0.62
26.0
8.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
49
1.63
0.62
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
63
1.59
0.61
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
49
407
1.21
0.61
1.1
1.2
u/ml
4.3
2.4
—
7
26
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
210
0.71
0.60
1.3
1.1
u/ml
4.5
3.5
—
5
56
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
27
209
1.30
0.60
1.4
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
221
0.72
0.60
1.1
1.1
u/ml
0.3
1.4
—
8
97
(3045424) Erythrocytes [Presence] in Urine
38
310
1.23
0.57
1.4
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
90
0.55
0.55
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
90
0.55
0.55
1.2
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
9
60
1.50
0.54
1.0
1.1
%
44.4
59.4
—
9
51
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
8
126
0.63
0.54
1.0
1.0
mg/l
222.4
316.6
—
8
111
(3023511) Choriogonadotropin [Units/volume] in Urine
15
108
1.39
0.53
1.5
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
63
1.43
0.52
1.0
1.0
miu/ml
1197.7
1552.0
—
9
63
(36660697) Celiac disease serology panel - Serum
133
1209
1.11
0.52
1.1
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
613
6354
0.95
0.49
4.1
3.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
55
474
1.16
0.49
1.6
1.5
u/l
10.7
7.3
0.81
44
384
(3022689) Creatine [Moles/volume] in Urine
7
45
1.56
0.49
1.7
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
178
0.73
0.48
1.4
1.1
u/ml
7.6
2.8
—
5
69
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
128
1.33
0.47
1.4
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
48
1.46
0.46
1.1
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
165
0.73
0.46
1.2
1.0
u/ml
19.2
4.6
—
5
66
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
49
1.43
0.46
1.4
1.2
%
117.9
108.8
—
7
41
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
120
0.67
0.45
1.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
84
0.59
0.45
1.4
2.3
umol/l
63.0
53.6
—
5
69
(3008295) Osmolality of Serum or Plasma
24
192
1.25
0.45
1.3
1.3
mosm/kgh2o
275.7
280.3
0.32
18
143
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
78
1.41
0.43
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
33
393
0.84
0.43
1.6
1.5
e6/l
170.3
29.5
0.40
26
301
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
33
393
0.84
0.43
1.6
1.6
e6/l
148.2
1000.1
1.16
28
312
(3024869) Neuronal Ab [Presence] in Serum
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(44813793)
6
93
0.64
0.42
1.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
32
1.56
0.42
1.2
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
32
1.56
0.42
8.2
6.9
—
—
—
0
0
(4027681)
6
94
0.64
0.42
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
17
131
1.30
0.42
1.2
1.5
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.0
—
24.9
—
0
9
(3042517) Benzodiazepines panel - Urine
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
59
1.36
0.41
1.1
1.0
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
17
0.00
0.40
0.0
1.4
—
7.0
—
0
8
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
88
1.37
0.40
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
207
1947
1.07
0.40
1.4
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
35
1.43
0.39
1.2
2.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
19
0.00
0.39
0.0
1.2
—
0.1
—
0
11
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
36
1.39
0.38
1.4
3.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
181
0.77
0.38
1.9
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
147
0.75
0.37
1.3
1.7
—
—
—
0
0
(4146454)
15
191
0.78
0.36
2.1
2.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
37
428
0.86
0.36
4.2
3.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
78
0.64
0.35
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
99
1.32
0.35
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
99
1.32
0.35
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
240
2281
1.06
0.35
4.9
4.3
%
30.0
31.0
0.73
185
1475
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
37
426
0.87
0.34
1.3
1.1
u/ml
13.4
7.7
—
7
47
(3009542) Hematocrit [Volume Fraction] of Blood
1615
15988
1.04
0.33
32.6
14.5
%
40.4
40.6
0.53
1154
11539
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
13
100
1.30
0.33
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
87
0.69
0.33
1.0
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
24
201
1.20
0.32
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
47
417
1.13
0.32
1.2
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
230
0.82
0.31
1.1
1.1
u/ml
6.7
6.0
0.10
12
115
(3026389) Candida sp identified in Specimen by Organism specific culture
21
174
1.21
0.31
1.6
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
50
447
1.12
0.30
1.8
2.1
—
—
—
0
0
(44806420)
7
54
1.30
0.30
2.7
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
224
2345
0.95
0.29
1.4
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
12
150
0.80
0.27
1.2
1.0
u/ml
0.8
0.6
—
5
43
(40761536) Microorganisms panel - Urine sediment
151
1435
1.06
0.25
3.8
3.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
17
202
0.84
0.24
1.1
1.2
mmol/l
8.1
7.2
0.50
11
151
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
25
217
1.15
0.24
1.0
1.1
u/ml
3.0
2.9
—
7
91
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
81
0.74
0.24
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
115
1.22
0.23
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
190
0.84
0.23
1.3
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
41
1.22
0.22
1.6
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
43
391
1.10
0.22
1.5
2.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.2
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
31
277
1.12
0.21
2.2
2.9
u/ml
3.7
254.9
0.97
31
269
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
272
0.88
0.20
1.4
1.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
49
1.23
0.20
1.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
58
1.21
0.18
1.3
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
60
1.17
0.17
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
91
1.21
0.17
1.6
1.2
nmol/l
144.6
140.7
0.09
11
91
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
61
1.15
0.17
1.1
2.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
184
1903
0.96
0.17
3.7
4.5
ug/l
10.6
27.7
1.48
155
1572
(3003740) Influenza virus B Ag [Presence] in Specimen
23
257
0.89
0.17
1.3
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
85
807
1.06
0.16
4.0
3.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
113
1180
0.96
0.16
2.0
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
23
256
0.90
0.16
1.3
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
168
1.13
0.15
1.2
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
80
1.13
0.15
1.8
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
363
3558
1.02
0.15
1.7
1.7
pmol/l
31715644.1
26214342.3
0.06
309
2945
(3034891) Synovial lining cells/100 cells in Synovial fluid
9
83
1.08
0.14
1.0
1.3
%
—
4.8
—
0
25
(3038177) Helicobacter pylori Ab [Presence] in Serum
23
254
0.90
0.14
1.2
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
12
139
0.86
0.14
4.7
5.4
u/ml
32.8
38.5
—
6
40
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
31
287
1.08
0.12
1.1
1.1
iu/ml
334.8
83.0
—
5
68
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
127
0.87
0.12
10.8
14.1
nmol/l
1007.0
802.6
0.59
11
121
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
95
1.16
0.11
1.3
3.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
40
424
0.94
0.11
1.6
1.4
iu/l
31.6
27.2
0.29
30
350
(3009466) Valproate [Moles/volume] in Serum or Plasma
32
299
1.07
0.10
5.3
5.2
umol/l
350.9
354.5
0.05
27
265
(3016018) Differential panel - Cerebral spinal fluid
22
202
1.09
0.10
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
261
1.07
0.10
1.4
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
87
1.15
0.09
3.9
3.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
134
0.89
0.08
1.8
1.9
u/field
2.3
1.7
—
7
52
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
63
0.79
0.08
1.4
2.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
13
117
1.11
0.08
1.2
1.2
mmol/l
43.8
34.0
0.42
13
102
(3006462) Nitrate [Presence] in Urine
7
66
1.06
0.08
1.7
3.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
71
0.84
0.07
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
98
1.12
0.07
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
25
266
0.94
0.07
1.3
1.3
—
—
—
0
0
(4024509)
13
143
0.91
0.07
1.7
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
42
402
1.05
0.07
1.4
1.4
mmol/l
3.7
3.7
0.06
37
378
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
44
422
1.04
0.07
2.5
3.9
u/ml
410.5
958.1
0.38
39
386
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
81
0.86
0.07
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
118
1.10
0.07
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
118
1.10
0.07
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
118
1.10
0.07
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
86
1.05
0.07
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
242
2389
1.01
0.06
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
58
563
1.03
0.05
1.6
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
87
851
1.02
0.05
2.6
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
71
727
0.98
0.05
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
48
495
0.97
0.05
2.0
2.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
120
1.08
0.05
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
120
1.08
0.05
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
120
1.08
0.05
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
692
6953
0.99
0.04
2.1
2.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
48
466
1.03
0.04
2.0
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
49
504
0.97
0.04
2.0
2.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
350
3526
0.99
0.04
4.6
3.5
kg/l
1.0
1.0
1.61
39
490
(3011288) Drugs identified in Urine by Screen method
31
322
0.96
0.04
2.7
3.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
17
160
1.06
0.04
1.5
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
49
503
0.97
0.04
2.0
2.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
37
359
1.03
0.03
1.8
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
167
1654
1.01
0.03
1.5
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
185
1838
1.01
0.02
2.1
2.5
ug/g
138.3
158.9
0.44
152
1473
(3000764) Benzodiazepines [Presence] in Urine
49
498
0.98
0.01
2.0
2.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
87
863
1.01
0.01
1.2
1.2
iu/ml
101.0
123.9
0.27
24
306
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
114
1.05
0.00
1.3
1.6
g/l
0.9
1.0
0.46
12
114
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
460
4608
1.00
0.00
1.5
1.6
mmol/l
1.5
1.4
1.45
403
3849
(3044290) Cell count panel - Cerebral spinal fluid
36
366
0.98
0.00
1.5
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
175
1.03
0.00
1.1
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
107
1066
1.00
0.00
1.9
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
11
107
1.03
0.00
1.9
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
103
0.97
0.00
1.0
1.2
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
9
0.00
0.00
0.0
1.1
—
0.7
—
0
9
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
90
1.00
0.00
1.0
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
8.4
—
0
5
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
52
0.96
0.00
1.4
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
97
0.93
0.00
6.6
6.7
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
75
0.93
0.00
1.4
1.5
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
8
85
0.94
0.00
1.3
1.6
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
69
0.87
0.00
4.0
3.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
51
0.98
0.00
2.4
1.3
ug/l
8.9
8.4
—
5
51
(3043410) Blood group antigens tested for on Red Blood Cells
5
55
0.91
0.00
2.4
2.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
7
75
0.93
0.00
1.7
3.4
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1475.5
—
0
6
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
8.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
88
0.91
0.00
1.1
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.8
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
61
0.98
0.00
1.2
1.4
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_NONISCHCARDMYOP_STRICT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_NONISCHCARDMYOP_STRICT | 2.931 [2.56, 3.36] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.147 |
During the follow-up period (1.1.1998 — 31.12.2019), 1023 out of 3592 females with I9_NONISCHCARDMYOP_STRICT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_NONISCHCARDMYOP_STRICT | 2.704 [2.44, 2.99] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 2926 out of 8846 males with I9_NONISCHCARDMYOP_STRICT died.
Mortality risk
Mortality risk for people of age
years, who have I9_NONISCHCARDMYOP_STRICT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.239% | 0.397% |
| 5 | 1.68% | 2.752% |
| 10 | 3.951% | 7.339% |
| 15 | 7.703% | 13.927% |
| 20 | 13.295% | 22.847% |
Relationships between endpoints
↥Index endpoint: I9_NONISCHCARDMYOP_STRICT – Nonischemic cardiomyopathy
GWS hits: 7
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data